Clinical Hours: Mon-Fri, 8AM - 3PM(905) 493-5700
1885 Glenanna Road, Suite 220, Pickering, ON, L1V 6R6
Histidine, collagen, hyaluronic acid, and oral ceramides are sold as drinkable moisturizers. A review of what the randomized trials show and where the evidence runs out.
Can skin be moisturized from the inside? The supplement industry has answered the question with confidence, and collagen drinks, hyaluronic acid capsules, ceramide tablets, and amino acid powders are all sold as moisturizers that happen to be swallowed. The scientific version of the question is narrower. Water content in the skin is governed by a small number of structures in the outermost layer, and an oral supplement can matter only if it supplies something those structures are short of, or changes how they are built.
The stratum corneum, the outermost layer of the epidermis, retains water through two mechanisms working together. Flattened corneocytes are embedded in a lipid matrix of ceramides, cholesterol, and free fatty acids that limits evaporation from the surface. Inside those cells sits the natural moisturizing factor, a mixture of water-binding compounds dominated by free amino acids and their derivatives.
Most of that natural moisturizing factor is derived from a single protein. Filaggrin is broken down in the upper stratum corneum into free amino acids, including histidine, which is further metabolized to urocanic acid. The importance of the pathway is demonstrated by genetics. Carriers of loss-of-function mutations in the filaggrin gene have measurably reduced natural moisturizing factor in the stratum corneum, and the reduction is proportional to the number of defective copies inherited [1].
This sets the standard that an oral moisturizer has to meet. A swallowed compound is digested, absorbed, and distributed through the circulation, and to influence stratum corneum hydration it must either supply a raw material that is genuinely limiting or change how the epidermis builds and retains its own water-binding molecules. Most marketed supplements are tested against a much softer standard, which is a measurable change in an instrument reading over eight to twelve weeks.
The simplest version of the idea is drinking more water. A systematic review of dietary fluid intake and skin hydration in healthy adults located only six eligible studies and judged the evidence weak in both quantity and methodological quality. Within that limitation, additional water intake was associated with a slight increase in stratum corneum hydration, most evident in individuals whose previous consumption had been low, and the biological mechanism for the association remains unknown [2].
The individual trials show the same pattern. In a study of 49 healthy women, approximately two litres of water were added to the daily diet for one month. Superficial and deep hydration were significantly modified, and the effect was concentrated in the group whose habitual intake had been below 3,200 mL per day [3].
Supported: correcting a fluid intake that is genuinely low. Overstated: the assumption that intake beyond ordinary needs keeps adding hydration. No trial has shown that an already well-hydrated person gains stratum corneum water by drinking more, and the quality of the evidence in this area does not support confident advice in either direction [2].
Histidine has the clearest mechanistic rationale of any oral option, because it sits directly in the pathway described above. Histidine is incorporated into filaggrin during synthesis of the protein and released again when filaggrin is broken down, becoming both a component of the natural moisturizing factor and the precursor of urocanic acid. Reduced stratum corneum levels of these amino acids are associated with the severity of atopic dermatitis and with filaggrin genotype [4].
The reasoning was tested in a randomized, double-blind, placebo-controlled crossover pilot study in 24 adults with atopic dermatitis. Participants took 4 g of oral L-histidine or an identical placebo once daily, dissolved in a morning drink. After four weeks of supplementation, disease severity fell by 34 percent on physician-assessed SCORAD and by 39 percent on the patient-reported Patient Oriented Eczema Measure, while no improvement was recorded during the placebo period. Laboratory work reported in the same paper showed increased filaggrin formation and improved barrier function in human skin-equivalent models [4].
A later report described a placebo-controlled pilot study in 49 young children with atopic dermatitis, mean age 3.5 years, taking 0.8 g of L-histidine daily. Eczema Area and Severity Index scores fell by 49 percent at 12 weeks, with no effect from placebo. A separate survey of 98 adults taking 4 g daily reported a 33 percent reduction in topical corticosteroid use, and no adverse event in either study was judged causally related to the supplement [5].
The caveats: these remain pilot studies. The adult trial randomized 24 patients, of whom 21 contributed analysable severity data, and no large confirmatory trial has followed. The endpoints were disease severity scores rather than direct measurements of skin hydration. One investigator is disclosed in the paper as a founding director of a university spin-out company holding patents in this field, which does not invalidate the finding but does argue for independent replication [4]. The population studied was atopic dermatitis, in which filaggrin processing is impaired; whether supplementation does anything for ordinary dry skin with normal filaggrin has not been tested.
Hydrolyzed collagen is the most heavily studied oral cosmetic supplement, and two independent meta-analyses point in the same direction. The first pooled 19 randomized, double-blind, controlled trials with 1,125 participants aged 20 to 70 years, of whom 95 percent were women, and found results favouring supplementation for skin hydration, elasticity, and wrinkles, with 90 days identified as an effective duration of ingestion [6]. The second pooled 26 randomized controlled trials with 1,721 participants and also found a significant improvement in skin hydration, while identifying several biases among the included trials and calling for large-scale confirmation [7].
The caveats: the endpoints are instrument readings of hydration and elasticity in healthy volunteers rather than treatment of a skin disease, the trials are short, the participants are predominantly middle-aged women, and the products tested are proprietary blends that often contain vitamins, antioxidants, or hyaluronic acid alongside the collagen, so the peptide itself is rarely isolated. The consistency across two separate meta-analyses is nonetheless more than most supplement categories can claim.
The best-designed trial of oral hyaluronic acid randomized 150 healthy adults to sodium hyaluronate at 60 mg daily, 120 mg daily, or placebo for 12 weeks. The higher dose significantly increased facial hydration and elasticity, reduced transepidermal water loss and periorbital wrinkle depth, and raised natural moisturizing factor components in forearm skin measured by mass spectrometry. The lower dose produced similar but more modest effects [8]. The trial was prospectively filed and placebo-controlled, which places it above most of its predecessors, and it was conducted by researchers employed by the manufacturer of the tested ingredient, which is common in this literature and is precisely why independent replication matters.
Ceramides are the lipids that seal the stratum corneum, so supplying them by mouth has obvious appeal. A randomized, double-blind, placebo-controlled trial gave adults concerned about dry skin a food containing 0.8 mg of dihydroceramide derived from acetic acid bacteria, or a placebo, for 12 weeks, and reported significantly improved stratum corneum hydration with no harmful effects [9]. The dose is small, the study was run by the research institute of the manufacturer, and the wider literature consists largely of trials of this size and design.
In a 12-week trial, women ingested 2.2 g of total fatty acids daily as flaxseed oil or borage oil, or a placebo containing medium-chain fatty acids. Transepidermal water loss fell by approximately 10 percent in both oil groups by week 6, and roughness and scaling were significantly reduced at week 12. Skin hydration increased in the oil groups, but hydration was also the one parameter that improved in the placebo group, which is the detail that separates a plausible finding from a proven one [10].
Where fatty acid supplements have been measured against a clinical endpoint, the results have been negative. A Cochrane review of 27 studies with 1,596 participants found that neither oral evening primrose oil nor borage oil improved global eczema symptoms compared with placebo [11]. The wider question of what diet can and cannot do in eczema is examined in the article on whether diet can cure eczema.
One category of oral treatment reliably repairs dry skin, and it is the category the supplement aisle rarely advertises: replacement of a nutrient that is actually deficient. Zinc deficiency produces a characteristic dermatitis, deficiency of essential fatty acids produces dry and scaly skin, and vitamin A deficiency produces the follicular hyperkeratosis known as phrynoderma. In each case the skin recovers when the deficiency is corrected [12]. That logic does not extend to a well-nourished person, in whom additional intake of a sufficient nutrient has no deficiency left to correct.
Persistent dryness also has causes that no supplement addresses. Skin that is dry, itchy, and recurrently inflamed is frequently a dermatitis rather than simple dryness, and it responds to anti-inflammatory treatment rather than to nutrition. Thyroid disease, renal disease, and several common medications produce xerosis as well, which is why dryness that does not settle with routine skin care warrants assessment rather than a longer supplement list.
The relevant comparison is not supplement against nothing, but supplement against the treatment already established. A Cochrane review of moisturisers in eczema included 77 studies with 6,603 participants and found that most moisturisers produced beneficial effects, worked better in combination with active treatment, prolonged the time to flare, and reduced both the number of flares and the amount of topical corticosteroid required [13]. Nothing in the oral literature approaches that evidence base, and the Canadian topical options are reviewed in the article on topical treatments for eczema.
Keep the order right. A low fluid intake is worth correcting. An emollient is worth applying consistently, because it delivers lipids and humectants directly to the layer that has to hold the water. Any underlying dermatitis is worth treating. Only after those steps does an oral supplement become a reasonable question. In atopic dermatitis, L-histidine has a coherent mechanism and pilot-scale evidence that deserves to be taken seriously and discussed with a dermatologist rather than started on the strength of a product label. Collagen peptides and oral hyaluronan produce small, measurable, instrument-recorded changes in cosmetic trials. Oral ceramides remain a thin literature, and evening primrose and borage oil have been tested and found ineffective.
A capsule does not replace a cream. Skin that stays dry despite regular emollient use is usually telling a clinical story rather than a nutritional one. A consultation at the Centre for Medical and Surgical Dermatology allows persistent dryness to be assessed, the underlying cause to be identified, and the treatment plan to be built on measures that have been shown to work.
This article is intended for educational purposes and does not replace professional medical advice. Please consult your dermatologist for personalized recommendations.
Your feedback helps us improve our news and clinical insights
From medical dermatology to surgical procedures, our clinic provides comprehensive care for all skin, hair, and nail conditions.